It is an irony that although lithium is not FDA approved as an augmentation strategy for treating depression, there is prob ...
Augmentation was more effective with quetiapine than lithium for treatment-resistant depression in a pragmatic trial. Quetiapine also improved quality-adjusted life years more than lithium. The ...
A nationwide Swedish cohort study included 105,495 individuals (mean age, 44.2 years; 62.2% women) diagnosed with bipolar disorder between 2006 and 2021 using data from national registers of inpatient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback